Clinical Research Directory
Browse clinical research sites, groups, and studies.
Brexanolone Lifting Outcomes Of Moms
Sponsor: Lipocine Inc.
Summary
The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause
Official title: A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression
Key Details
Gender
FEMALE
Age Range
15 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-09
Completion Date
2027-09
Last Updated
2026-09-16
Healthy Volunteers
No
Conditions
Interventions
LPCN 1154A
Oral LPCN 1154A tablets for 48 hours
Placebo
Oral Placebo Tablets for 48 hours
Locations (16)
Lipocine Investigational Site
Tucson, Arizona, United States
Lipocine Investigational Site
Canoga Park, California, United States
Lipocine Investigational Site
Walnut Creek, California, United States
Lipocine Investigational Site
Aurora, Colorado, United States
Lipocine Investigational Site
Decatur, Georgia, United States
Lipocine Investigational Site
Idaho Falls, Idaho, United States
Lipocine Investigational Site
Chicago, Illinois, United States
Lipocine Investigational Site
New Orleans, Louisiana, United States
Lipocine Investigational Site
Las Vegas, Nevada, United States
Lipocine Investigational Site
Princeton, New Jersey, United States
Lipocine Investigational Site
Manhattan, New York, United States
Lipocine Investigational Site
Chapel Hill, North Carolina, United States
Lipocine Investigational Site
Plano, Texas, United States
Lipocine Investigational Site
Richardson, Texas, United States
Lipocine Investigational Site
Clinton, Utah, United States
Lipocine Investigational Site
Orem, Utah, United States